Sepsis outcomes in patients receiving statins prior to hospitalization for sepsis: comparison of in-hospital mortality rates between patients who received atorvastatin and those who received simvastatin

作者: Daniel R Ouellette , Erics Espinoza Moscoso , Julio Pinto Corrales , Michael Peters

DOI: 10.1186/S13613-015-0049-9

关键词:

摘要: The purpose of this study is to compare the in-hospital mortality rates between septic patients receiving statins and those that did not prior developing sepsis. We compared subgroups atorvastatin simvastatin because these two drugs differ in their pharmacologic properties. This was a retrospective analysis selected from an institutional data base hospitalized with were drawn 1,961 sepsis included who met selection criteria studied for HMG-CoA reductase inhibitor (statin) use both during hospitalization. compared. In-hospital patient also A multivariable conducted as outcome variable multiple risk factors include use. rate 359 hospitalization significantly different than 1,302 receive pre-hospital (26.5% versus 30.4%, p > 0.05). 92 had received less 253 (18.5% 30.0%, p = 0.032). independently associated lower (p = 0.021, OR = 0.455). Patients continued hospital very low never (15.7% 30.8%, p = 0.007). Pre-hospital improved when other factors. effect may be individual statins.

参考文章(35)
Mitchell M. Levy, R Phillip Dellinger, Sean R. Townsend, Walter T. Linde-Zwirble, John C. Marshall, Julian Bion, Christa Schorr, Antonio Artigas, Graham Ramsay, Richard Beale, Margaret M. Parker, Herwig Gerlach, Konrad Reinhart, Eliezer Silva, Maurene Harvey, Susan Regan, Derek C. Angus, The Surviving Sepsis Campaign: Results of an international guideline-based performance improvement program targeting severe sepsis* Critical Care Medicine. ,vol. 38, pp. 367- 374 ,(2010) , 10.1097/CCM.0B013E3181CB0CDC
Yaniv Almog, Alexander Shefer, Victor Novack, Nimrod Maimon, Leonid Barski, Miruna Eizinger, Michael Friger, Lior Zeller, Abraham Danon, Prior Statin Therapy Is Associated With a Decreased Rate of Severe Sepsis Circulation. ,vol. 110, pp. 880- 885 ,(2004) , 10.1161/01.CIR.0000138932.17956.F1
Pedro R. Póvoa, António H. Carneiro, Orquídea S. Ribeiro, Altamiro C. Pereira, Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study). Critical Care Medicine. ,vol. 37, pp. 410- 416 ,(2009) , 10.1097/CCM.0B013E3181958B1C
You-Dong Wan, Tong-Wen Sun, Quan-Cheng Kan, Fang-Xia Guan, Shu-Guang Zhang, Effect of statin therapy on mortality from infection and sepsis: a meta-analysis of randomized and observational studies Critical Care. ,vol. 18, pp. 1- 13 ,(2014) , 10.1186/CC13828
Anand Kumar, Daniel Roberts, Kenneth E. Wood, Bruce Light, Joseph E. Parrillo, Satendra Sharma, Robert Suppes, Daniel Feinstein, Sergio Zanotti, Leo Taiberg, David Gurka, Aseem Kumar, Mary Cheang, Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Critical Care Medicine. ,vol. 34, pp. 1589- 1596 ,(2006) , 10.1097/01.CCM.0000217961.75225.E9
Tara Lagu, Michael B. Rothberg, Meng-Shiou Shieh, Penelope S. Pekow, Jay S. Steingrub, Peter K. Lindenauer, Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Critical Care Medicine. ,vol. 40, pp. 754- 761 ,(2012) , 10.1097/CCM.0B013E318232DB65
Sharon Leung, Reha Pokharel, Michelle N. Gong, Statins and outcomes in patients with bloodstream infection: a propensity-matched analysis. Critical Care Medicine. ,vol. 40, pp. 1064- 1071 ,(2012) , 10.1097/CCM.0B013E31823BC9E7
Peter Kruger, Michael Bailey, Rinaldo Bellomo, David James Cooper, Meg Harward, Alisa Higgins, Belinda Howe, Darryl Jones, Chris Joyce, Karam Kostner, John McNeil, Alistair Nichol, Michael S Roberts, Gillian Syres, Bala Venkatesh, ANZ-STATInS Investigators–ANZICS Clinical Trials Group, None, A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis American Journal of Respiratory and Critical Care Medicine. ,vol. 187, pp. 743- 750 ,(2013) , 10.1164/RCCM.201209-1718OC
Michael Schachter, Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update Fundamental & Clinical Pharmacology. ,vol. 19, pp. 117- 125 ,(2005) , 10.1111/J.1472-8206.2004.00299.X